Investigational Drug Information for Velusetrag
✉ Email this page to a colleague
What is the development status for investigational drug Velusetrag?
Velusetrag is an investigational drug.
There have been 4 clinical trials for Velusetrag.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 15th 2021.
The most common disease conditions in clinical trials are Gastroparesis, Intestinal Pseudo-Obstruction, and Alzheimer Disease. The leading clinical trial sponsors are Theravance Biopharma, Theravance Biopharma R & D, Inc., and Alfasigma S.p.A.
Summary for Velusetrag
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 47 |
| WIPO Patent Applications | 22 |
| Japanese Patent Applications | 5 |
| Clinical Trial Progress | Phase 2 (2021-12-15) |
| Vendors | 23 |
Recent Clinical Trials for Velusetrag
| Title | Sponsor | Phase |
|---|---|---|
| Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO). | Alfasigma S.p.A. | Phase 2 |
| The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study | Alfa Wassermann S.p.A. | Phase 2 |
| The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study | Alfasigma S.p.A. | Phase 2 |
Clinical Trial Summary for Velusetrag
Top disease conditions for Velusetrag
Top clinical trial sponsors for Velusetrag
US Patents for Velusetrag
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
